APA (7th ed.) Citation

Curtis, J. R., Deodhar, A., Soriano, E. R., Rampakakis, E., Shawi, M., Shiff, N. J., . . . Gladman, D. D. (2024). Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis: Post hoc Analyses of Two Phase 3 Trials. Rheumatology & Therapy, 11(6), 1501. https://doi.org/10.1007/s40744-024-00702-0

Chicago Style (17th ed.) Citation

Curtis, Jeffrey R., Atul Deodhar, Enrique R. Soriano, Emmanouil Rampakakis, May Shawi, Natalie J. Shiff, Chenglong Han, William Tillett, and Dafna D. Gladman. "Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis: Post Hoc Analyses of Two Phase 3 Trials." Rheumatology & Therapy 11, no. 6 (2024): 1501. https://doi.org/10.1007/s40744-024-00702-0.

MLA (9th ed.) Citation

Curtis, Jeffrey R., et al. "Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis: Post Hoc Analyses of Two Phase 3 Trials." Rheumatology & Therapy, vol. 11, no. 6, 2024, p. 1501, https://doi.org/10.1007/s40744-024-00702-0.